![Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX]](https://cedclinic.com/wp-content/uploads/2026/06/ced-unsplash-ke6jYtwXDKA-1-150x150.jpg "Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX] 18")
White House National Drug Control Strategy Presents Conflicting Stances on Medical …
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchMental HealthSafety Why This Matters Clinicians need clarity on federal cannabis policy to confidently…
‘Fitness, fresh air and forward thinking’: Cape to Cape for Cannabis delivers a new kind of …
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchIndustryPolicy Clinical Summary # Cannabis Clinical Summary Medical Cannabis Research Australia (MCRA) organized…
Health Ministry updates guidelines for medical cannabis perscription | The Jerusalem Post
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyMedical CannabisPainPTSDAging Why This Matters Israel’s updated medical cannabis guidelines establish clearer…
Health Ministry panel seeks to halt use of medical cannabis in smokable form
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicySafetyMental HealthNeurology Why This Matters Clinicians need to understand this policy shift because…
New cannabis-hemp extract rules take effect, limiting use to four purposes – Nation Thailand
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempIndustry Why This Matters Thailand’s new cannabis-hemp extract regulations establish clear medical…
New Top Cannabis Regulator Sets Priorities In First Board Meeting
The new cannabis regulatory priorities focus on improving product safety and testing standards. These changes directly affect clinical practice and patient access. Clinicians must stay informed about evolving regulations to guide patients effectively.
Georgia House Passes Bill to Expand Medical Cannabis Program
Georgia medical cannabis expansion will increase patient eligibility and require clinicians to update screening and dosing protocols. The new bill reflects evidence-based policy development. Providers should prepare for changes in clinical practice and…
Patients Call for Global Medical Cannabis Laws to End Border Arrests
Cannabis legality international travel remains a critical issue as patients face severe legal risks crossing borders with medical cannabis. This article highlights the urgent need for global medical cannabis laws to prevent border arrests. Clinicians…
CED Digest: 405 Items — March 12, 2026
CED DigestMarch 12, 2026. 405 items curated for clinical relevance. Above Threshold #97 Alabama Medical Cannabis Sales Gear for Spring 2026 Launch Summary Alabama’s medical cannabis program is preparing to begin patient sales in spring 2026,…
Marijuana – Point of View
Cannabis safety research is essential for clinicians to provide informed counseling about cannabis risks. Emerging evidence highlights the importance of understanding adverse effects. This research supports balanced clinical guidance on cannabis use.